Embecta Corp. (FRA:JX7)
Germany · Delayed Price · Currency is EUR 12.30
+0.60 (5.13%)
Last updated: Nov 24, 2025, 3:29 PM CET
Embecta Company Description
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally.
The company’s products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient’s diabetes.
It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Embecta Corp.
| Country | United States |
| Founded | 1924 |
| Industry | Orthopedic, Prosthetic, and Surgical Appliances and Supplies |
| Employees | 2,100 |
| CEO | Devdatt Kurdikar |
Contact Details
Address: 300 Kimball Drive Parsippany, Delaware 07054 United States | |
| Phone | 862 401 0000 |
| Website | embecta.com |
Stock Details
| Ticker Symbol | JX7 |
| Exchange | Frankfurt Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Devdatt Kurdikar | Chief Executive Officer |
| Jacob Elguicze | Chief Financial Officer |
| Pravesh Khandelwal | Head of Investor Relations |